...
首页> 外文期刊>Toxicology Letters: An International Journal Providing a Forum for Original and Pertinent Contributions in Toxicology Research >Concomitant administration of an isopropanolic extract of black cohosh and tamoxifen in the in vivo tumor model of implanted RUCA-I rat endometrial adenocarcinoma cells.
【24h】

Concomitant administration of an isopropanolic extract of black cohosh and tamoxifen in the in vivo tumor model of implanted RUCA-I rat endometrial adenocarcinoma cells.

机译:黑升麻和他莫昔芬的异丙醇提取物在植入的RUCA-1大鼠子宫内膜腺癌细胞的体内肿瘤模型中的同时给药。

获取原文
获取原文并翻译 | 示例

摘要

Black cohosh is a well known herbal remedy of long traditional use against menopausal complaints. Recently published studies on postmenopausal hormone replacement with synthetic substances associated severe negative side effects with an increase in duration of administration. The subsequent popularity of alternative treatments, often herbal drugs, made investigations into the safety of these preparations more pressing. Until now, black cohosh demonstrated no estrogen-agonistic activity in mammary cells, neither in animal model nor in cell culture, i.e., no gene transcription or cell proliferation was induced. Here we tested for the influence of a standardized isopropanolic extract of black cohosh on an animal model of endometrial cancer. Ectopic growth of the primary tumor as well as the incidence and localization of metastases were examined, partly in the setting of a combination treatment with tamoxifen. In contrast to the endometrial estrogen agonist tamoxifen, black cohosh did not further growth ormetastasizing potential of the primary tumor. Absence of detectable supportive or antagonistic effects between both treatments most probable come from the relatively high tamoxifen dose.
机译:黑升麻是众所周知的草药疗法,可长期用于绝经期。最近发表的有关用合成物质替代绝经后激素的研究表明,严重的副作用与给药时间的延长有关。随后的替代疗法(通常是草药)的流行使对这些制剂的安全性的研究更加紧迫。迄今为止,黑升麻在动物模型和细胞培养中均未在乳腺细胞中显示雌激素激动活性,即未诱导基因转录或细胞增殖。在这里,我们测试了黑升麻的标准化异丙醇提取物对子宫内膜癌动物模型的影响。检查了原发肿瘤的异位生长以及转移的发生率和定位,部分是在与他莫昔芬联合治疗的背景下进行的。与子宫内膜雌激素激动剂他莫昔芬相反,黑升麻没有进一步生长或转移原发肿瘤的潜力。两种治疗之间最可能缺乏可检测的支持或拮抗作用的原因是他莫昔芬剂量相对较高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号